184 related articles for article (PubMed ID: 35904886)
1. The development of peripheral microvasculopathy with chronic metabolic disease in obese Zucker rats: a retrograde emergence?
Halvorson BD; Menon NJ; Goldman D; Frisbee SJ; Goodwill AG; Butcher JT; Stapleton PA; Brooks SD; d'Audiffret AC; Wiseman RW; Lombard JH; Brock RW; Olfert IM; Chantler PD; Frisbee JC
Am J Physiol Heart Circ Physiol; 2022 Sep; 323(3):H475-H489. PubMed ID: 35904886
[TBL] [Abstract][Full Text] [Related]
2. Chronic atorvastatin and exercise can partially reverse established skeletal muscle microvasculopathy in metabolic syndrome.
Lemaster KA; Frisbee SJ; Dubois L; Tzemos N; Wu F; Lewis MT; Wiseman RW; Frisbee JC
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H855-H870. PubMed ID: 29932769
[TBL] [Abstract][Full Text] [Related]
3. Integration of skeletal muscle resistance arteriolar reactivity for perfusion responses in the metabolic syndrome.
Frisbee JC; Hollander JM; Brock RW; Yu HG; Boegehold MA
Am J Physiol Regul Integr Comp Physiol; 2009 Jun; 296(6):R1771-82. PubMed ID: 19386988
[TBL] [Abstract][Full Text] [Related]
4. Altered post-capillary and collecting venular reactivity in skeletal muscle with metabolic syndrome.
Lemaster KA; Farid Z; Brock RW; Shrader CD; Goldman D; Jackson DN; Frisbee JC
J Physiol; 2017 Aug; 595(15):5159-5174. PubMed ID: 28556909
[TBL] [Abstract][Full Text] [Related]
5. Increased peripheral vascular disease risk progressively constrains perfusion adaptability in the skeletal muscle microcirculation.
Frisbee JC; Butcher JT; Frisbee SJ; Olfert IM; Chantler PD; Tabone LE; d'Audiffret AC; Shrader CD; Goodwill AG; Stapleton PA; Brooks SD; Brock RW; Lombard JH
Am J Physiol Heart Circ Physiol; 2016 Feb; 310(4):H488-504. PubMed ID: 26702145
[TBL] [Abstract][Full Text] [Related]
6. Shifted vascular optimization: the emergence of a new arteriolar behaviour with chronic metabolic disease.
Frisbee JC; Halvorson BD; Lewis MT; Wiseman RW
Exp Physiol; 2020 Sep; 105(9):1431-1439. PubMed ID: 32045062
[TBL] [Abstract][Full Text] [Related]
7. Remodeling of the skeletal muscle microcirculation increases resistance to perfusion in obese Zucker rats.
Frisbee JC
Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H104-11. PubMed ID: 12649071
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetes mellitus in the Goto-Kakizaki rat impairs microvascular function and contributes to premature skeletal muscle fatigue.
Frisbee JC; Lewis MT; Kasper JD; Chantler PD; Wiseman RW
J Appl Physiol (1985); 2019 Mar; 126(3):626-637. PubMed ID: 30571284
[TBL] [Abstract][Full Text] [Related]
9. Divergence between arterial perfusion and fatigue resistance in skeletal muscle in the metabolic syndrome.
Frisbee JC; Goodwill AG; Butcher JT; Olfert IM
Exp Physiol; 2011 Mar; 96(3):369-83. PubMed ID: 21123363
[TBL] [Abstract][Full Text] [Related]
10. Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome.
Frisbee JC
Am J Physiol Regul Integr Comp Physiol; 2005 Aug; 289(2):R307-R316. PubMed ID: 15802560
[TBL] [Abstract][Full Text] [Related]
11. Spatial heterogeneity in skeletal muscle microvascular blood flow distribution is increased in the metabolic syndrome.
Frisbee JC; Wu F; Goodwill AG; Butcher JT; Beard DA
Am J Physiol Regul Integr Comp Physiol; 2011 Oct; 301(4):R975-86. PubMed ID: 21775645
[TBL] [Abstract][Full Text] [Related]
12. Blunted temporal activity of microvascular perfusion heterogeneity in metabolic syndrome: a new attractor for peripheral vascular disease?
Butcher JT; Goodwill AG; Stanley SC; Frisbee JC
Am J Physiol Heart Circ Physiol; 2013 Feb; 304(4):H547-58. PubMed ID: 23262133
[TBL] [Abstract][Full Text] [Related]
13. Impact of chronic anticholesterol therapy on development of microvascular rarefaction in the metabolic syndrome.
Goodwill AG; Frisbee SJ; Stapleton PA; James ME; Frisbee JC
Microcirculation; 2009 Nov; 16(8):667-84. PubMed ID: 19905967
[TBL] [Abstract][Full Text] [Related]
14. Insidious incrementalism: The silent failure of the microcirculation with increasing peripheral vascular disease risk.
Lemaster K; Jackson D; Goldman D; Frisbee JC
Microcirculation; 2017 Feb; 24(2):. PubMed ID: 28236373
[TBL] [Abstract][Full Text] [Related]
15. Thromboxane-induced cerebral microvascular rarefaction predicts depressive symptom emergence in metabolic disease.
Halvorson BD; Bao Y; Singh KK; Frisbee SJ; Hachinski V; Whitehead SN; Melling CWJ; Chantler PD; Goldman D; Frisbee JC
J Appl Physiol (1985); 2024 Jan; 136(1):122-140. PubMed ID: 37969083
[TBL] [Abstract][Full Text] [Related]
16. Impaired hemorrhage tolerance in the obese Zucker rat model of metabolic syndrome.
Frisbee JC
J Appl Physiol (1985); 2006 Feb; 100(2):465-73. PubMed ID: 16223976
[TBL] [Abstract][Full Text] [Related]
17. Distinct temporal phases of microvascular rarefaction in skeletal muscle of obese Zucker rats.
Frisbee JC; Goodwill AG; Frisbee SJ; Butcher JT; Brock RW; Olfert IM; DeVallance ER; Chantler PD
Am J Physiol Heart Circ Physiol; 2014 Dec; 307(12):H1714-28. PubMed ID: 25305181
[TBL] [Abstract][Full Text] [Related]
18. Impaired skeletal muscle perfusion in obese Zucker rats.
Frisbee JC
Am J Physiol Regul Integr Comp Physiol; 2003 Nov; 285(5):R1124-34. PubMed ID: 12855417
[TBL] [Abstract][Full Text] [Related]
19. Vascular adrenergic tone and structural narrowing constrain reactive hyperemia in skeletal muscle of obese Zucker rats.
Frisbee JC
Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H2066-74. PubMed ID: 16373580
[TBL] [Abstract][Full Text] [Related]
20. Enhanced arteriolar alpha-adrenergic constriction impairs dilator responses and skeletal muscle perfusion in obese Zucker rats.
Frisbee JC
J Appl Physiol (1985); 2004 Aug; 97(2):764-72. PubMed ID: 15075303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
